Newron Pharmaceuticals S.p.A. (OTCMKTS:NWPHF) Short Interest Update

Newron Pharmaceuticals S.p.A. (OTCMKTS:NWPHF) saw a significant growth in short interest in the month of November. As of November 30th, there was short interest totalling 100,700 shares, a growth of 15.5% from the November 15th total of 87,200 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

Newron Pharmaceuticals Price Performance

Shares of Newron Pharmaceuticals stock remained flat at $9.36 on Monday. The stock has a 50-day moving average price of $9.36 and a 200 day moving average price of $10.07. Newron Pharmaceuticals has a one year low of $9.10 and a one year high of $12.00.

About Newron Pharmaceuticals

Newron Pharmaceuticals S.p.A., a biopharmaceutical company, focus on the development of novel therapies for the treatment of central nervous system (CNS) and pain in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson's in the European Union, Switzerland, the United Kingdom, the United States of America, Australia, Canada, Latin America, Israel, the United Arab Emirates, Japan, and South Korea.